Open access
Open access
Powered by Google Translator Translator

Hematology

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

12 Aug, 2020 | 02:20h | UTC

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy – Cancer

Commentary: New guidelines for managing mucositis now available – University of Rochester Medical Center

 


Peripheral blood examination findings in SARS-CoV-2 infection

10 Aug, 2020 | 01:58h | UTC

Peripheral Blood Examination Findings in SARS-CoV-2 Infection – American Journal of Clinical Pathology

 


Study: Bleeding and thrombotic manifestations of SARS-CoV-2 infection

7 Aug, 2020 | 03:16h | UTC

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection – Blood

Invited commentary: COVID-19 coagulopathy, thrombosis, and bleeding – Blood

 


Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

4 Aug, 2020 | 03:01h | UTC

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection – Nature Medicine

Commentary: Ancient part of immune system may underpin severe COVID – Columbia University Irving Medical Center

 

Commentary on Twitter

 


Management and prevention of anemia (acute bleeding excluded) in adult critical care patients

23 Jul, 2020 | 08:21h | UTC

Management and prevention of anemia (acute bleeding excluded) in adult critical care patients – Annals of Intensive Care

 


[Abstract Only] Randomized trial: Carfilzomib, dexamethasone, and daratumumab vs. carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

22 Jul, 2020 | 02:11h | UTC

Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study – The Lancet

 


Thrombosis in hospitalized patients with COVID-19 in a New York City health system

21 Jul, 2020 | 09:21h | UTC

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System – JAMA

 


Hematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19

16 Jul, 2020 | 08:24h | UTC

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study – The Lancet Haematology

Commentary: Coagulation disorder in COVID-19 – The Lancet Haematology

 

Related Commentary on Twitter

 


ACC Consensus on management of anticoagulant-related bleeding

15 Jul, 2020 | 08:12h | UTC

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Key Points: ACC Consensus on Management of Anticoagulant-Related Bleeding

 


Review: Extrapulmonary Manifestations of COVID-19

13 Jul, 2020 | 00:28h | UTC

Extrapulmonary manifestations of COVID-19 – Nature Medicine

Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology

 


Updated Systematic Review: Convalescent Plasma or Hyperimmune Immunoglobulin for COVID‐19

13 Jul, 2020 | 00:13h | UTC

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review – Cochrane Library

Commentary: Convalescent plasma to treat people with COVID-19: the evidence so far – Evidently Cochrane

 

Related Commentary on Twitter

 


[Preprint] Randomized Trial: Convalescent Plasma for COVID-19

6 Jul, 2020 | 08:47h | UTC

Convalescent Plasma for COVID-19. A randomized clinical trial – medRxiv

 

Related Commentary on Twitter

 


Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa

30 Jun, 2020 | 07:41h | UTC

Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa – New England Journal of Medicine

Commentary: Researchers discover improved treatment for children with sickle cell anemia – Indiana University

 


Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients

29 Jun, 2020 | 09:03h | UTC

Updated Guidelines to Reduce Venous Thromboembolism in Trauma Patients: A Western Trauma Association Critical Decisions Algorithm – Trauma and Acute Care Surgery

 


Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges

23 Jun, 2020 | 08:19h | UTC

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges – Journal of the American Heart Association

 


Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk

18 Jun, 2020 | 09:12h | UTC

Genomewide Association Study of Severe Covid-19 with Respiratory Failure – New England Journal of Medicine

Commentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press

 


Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19

18 Jun, 2020 | 09:03h | UTC

Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy – Hematology, Transfusion and Cell Therapy

 


Thromboelastographic Results and Hypercoagulability Syndrome in Patients with Coronavirus Disease 2019 Who Are Critically Ill

16 Jun, 2020 | 07:58h | UTC

Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill – JAMA Network Open

Commentary: Researchers recommend TEG test to identify undetected blood clots in COVID-19 ICU patients – Baylor College of Medicine

 


[Preprints Studies] Relationship Between Blood Group and Risk of Infection and Death in COVID-19

11 Jun, 2020 | 09:28h | UTC

Study 1: Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis – medRxiv AND Commentary:  Blood type plays role in SARS-CoV-2 infection – News Medical

Study 2: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis – medRxiv AND Commentary:  The Role Of Blood Type In Covid-19 Infection And Respiratory Failure – Forbes

 


Risk of Hospitalization with Hemorrhage Among Older Adults Taking Clarithromycin vs. Azithromycin and Direct Oral Anticoagulants

9 Jun, 2020 | 04:33h | UTC

Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants – JAMA Internal Medicine

 


CHEST Guideline: Prevention, Diagnosis and Treatment of Venous Thromboembolism in Patients with COVID-19

8 Jun, 2020 | 04:39h | UTC

Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report – CHEST

 


Convalescent Plasma Therapy Shows Promise for Severe COVID-19 in Small Randomized Trial

4 Jun, 2020 | 05:08h | UTC

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial – JAMA

Editorial: A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals – JAMA

 


Blood Vessel Attack Could Trigger Coronavirus’ Fatal ‘Second Phase’

3 Jun, 2020 | 03:56h | UTC

Blood vessel attack could trigger coronavirus’ fatal ‘second phase’ – Science

 


Observational Study: Many Patients with Covid-19 in the ICU Develop Thromboembolism Despite Routine Prophylaxis

29 May, 2020 | 03:17h | UTC

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 – Critical Care Medicine

 


Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis

29 May, 2020 | 03:03h | UTC

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials – Research and Practice in Thrombosis and Haemostasis

“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”

 


Stay Updated in Your Specialty

 

No spam, just news.